August 2011: Volume 37, Number 8
For Further Information
Bonello L, Tantry US, Marcucci R, Blindt R, et al. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate. JACC 2010;56:919-33.
Cattaneo, M. New P2Y12 Inhibitors. Circulation 2010;121:171-79.
Ferreiro JL, Sibbing D, Angiolillo DJ. Platelet function testing and risk of bleeding complications. Thromb Haemost 2010;103:1128-35.
Gurbel PA, Mahla E, Tantry US. Peri-operative platelet function testing: The potential for reducing ischaemic and bleeding risks. Thromb Haemost 2011;106.1/2011.
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2009;30:426–35.
Kwak YL, Kim JC, Choi YS, Yoo KJ, et al. Clopidogrel Responsiveness Regardless of the Discontinuation Date Predicts Increased Blood Loss and Transfusion Requirement after Off-Pump Coronary Artery Bypass Graft Surgery. JACC 2010;56:1994-2002.
Lordkipanidze M, Pharand C, Nguyen TA, Schampaert E, et al. Comparison of four tests to assess inhibition of platelet function by clopidogrel in stable coronary artery disease patients. Eur Heart J 2008;29:2877–85.
Montalescot G, Hulot, JS, Collet JP. Antiplatelet Therapy and Coronary Artery Bypass Graft Surgery. JACC 2010;56:2003-5.
Madsen EH, Saw J, Kristensen SR, Schmidt EB, et al. Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, VerifyNow, and thromboelastography in patients undergoing percutaneous coronary intervention. Clin Chem 2010;56:839–47.